Crescent Biopharma annual operating margin
2012
2013
2014
2015
2016
2020
2021
2022
2023
2025
Crescent Biopharma Operating Margin Growth & History (CBIO)
Crescent Biopharma's operating margin was −1,407.52% for fiscal 2025.
View full Crescent Biopharma company overviewCrescent Biopharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,407.52% | +391345.41 pp |
| 2023 | 2023-12-31 | −392,752.93% | −329548.50 pp |
| 2022 | 2022-12-31 | −63,204.43% | −57733.74 pp |
| 2021 | 2021-12-31 | −5,470.69% | −4963.85 pp |
| 2020 | 2020-12-31 | −506.84% | +171998.49 pp |
| 2016 | 2016-12-31 | −172,505.32% | −172441.63 pp |
| 2015 | 2015-12-31 | −63.70% | +10.43 pp |
| 2014 | 2014-12-31 | −74.13% | +191.52 pp |
| 2013 | 2013-12-31 | −265.65% | −289.47 pp |
| 2012 | 2012-12-31 | 23.82% | — |
Crescent Biopharma quarterly operating margin
Q1.13
Q2.13
Q3.13
Q4.13
Q2.14
Q3.14
Q2.15
Q3.15
Q3.16
Q1.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.22
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −2,380.08% | +10141621.33 pp |
| Q2 2022 | 2022-06-30 | −17,804.21% | −16451.23 pp |
| Q4 2021 | 2021-12-31 | −98,875.81% | −89320.86 pp |
| Q3 2021 | 2021-09-30 | −20,028.82% | −18656.09 pp |
| Q2 2021 | 2021-06-30 | −10,144,001.41% | −10143911.32 pp |
| Q1 2021 | 2021-03-31 | −1,352.98% | +41278.13 pp |
| Q4 2020 | 2020-12-31 | −9,554.94% | −9519.15 pp |
| Q3 2020 | 2020-09-30 | −1,372.73% | −1424.57 pp |
| Q1 2020 | 2020-03-31 | −90.09% | −45.51 pp |
| Q3 2016 | 2016-09-30 | −42,631.11% | −42684.78 pp |
| Q3 2015 | 2015-09-30 | −35.79% | +4960.00 pp |
| Q2 2015 | 2015-06-30 | 51.84% | +7091.66 pp |
| Q3 2014 | 2014-09-30 | −44.58% | +6304.98 pp |
| Q2 2014 | 2014-06-30 | 53.66% | +41.62 pp |
| Q4 2013 | 2013-12-31 | −4,995.80% | — |
| Q3 2013 | 2013-09-30 | −7,039.81% | — |
| Q2 2013 | 2013-06-30 | −6,349.56% | — |
| Q1 2013 | 2013-03-31 | 12.05% | — |
Crescent Biopharma operating margin trends
Over the last five reported fiscal years, Crescent Biopharma's operating margin increased from −172,505.32% to −1,407.52%, a change of +171097.80 percentage points. The latest reported quarter, Q1 2026, shows −2,380.08%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crescent Biopharma filings at SEC.gov ↗